MTAC P/E Ratio
P/E Ratio as of Dec 16, 2025: -3.68
Average-3.14
Median-3.32
Minimum-3.72
Maximum-2.22
-3.68
1.42 (62.83%)past month
The P/E ratio for MTAC is -3.68 as of Dec 16, 2025. This represents a increase of 2.51% compared to its 12-month average P/E ratio of -3.59. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
MedTech Acquisition Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
MedTech Acquisition Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing MedTech Acquisition Corp to industry peers.
MedTech Acquisition Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
MedTech Acquisition Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing MedTech Acquisition Corp to industry peers.
MTAC P/E Ratio Insights
See MedTech Acquisition Corp’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in MTAC
Order type
Buy in
Order amount
Est. shares
0 shares
MTAC P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Dec 1, 2025 | $7.00 | -3.47 |
| Nov 3, 2025 | $4.71 | -4.00 |
| Oct 1, 2025 | $4.56 | -3.87 |
| Sep 2, 2025 | $5.16 | -4.38 |
| Aug 1, 2025 | $4.18 | -3.73 |
| Jul 1, 2025 | $5.15 | -4.60 |
| Jun 2, 2025 | $5.21 | -4.65 |
| May 1, 2025 | $5.09 | -3.82 |
| Apr 1, 2025 | $5.50 | -4.13 |
| Mar 3, 2025 | $5.65 | -2.26 |
| Feb 3, 2025 | $5.33 | -2.13 |
| Jan 2, 2025 | $4.98 | -1.99 |
MTAC End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -3.68 | +84.00% |
| 2024 | -2.00 | -91.66% |
| 2023 | -23.99 | — |
FAQs About MedTech Acquisition Corp (MTAC) P/E ratio
The latest P/E ratio of MTAC is -3.68, as of Dec 16, 2025. This is calculated based on its current stock price and earnings per share (EPS).
MedTech Acquisition Corp’s last 12-month average P/E ratio is -3.59, compared to its current P/E ratio of -3.68. This reflects a increase of 2.51%.
MedTech Acquisition Corp’s current P/E ratio of -3.68 is higher than its last 12-month average P/E of -3.59. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
MedTech Acquisition Corp’s average P/E ratio over the last 3 years is -5.77. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
MedTech Acquisition Corp’s average P/E ratio over the last 5 years is -3.46. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.